about
Zika virus: An update on epidemiology, pathology, molecular biology, and animal modelZika virus update II: Recent development of animal models - proofs of association with human pathogenesisHIV, EBV and KSHV: viral cooperation in the pathogenesis of human malignancies.Human DNA tumor viruses generate alternative reading frame proteins through repeat sequence recoding.An Oncogenic Virus Promotes Cell Survival and Cellular Transformation by Suppressing GlycolysisViral cyclin promotes KSHV-induced cellular transformation and tumorigenesis by overriding contact inhibition.Tenovin-6 inhibits proliferation and survival of diffuse large B-cell lymphoma cells by blocking autophagy.Human gammaherpesviruses viraemia in HIV infected patients.The central repeat domain 1 of Kaposi's sarcoma-associated herpesvirus (KSHV) latency associated-nuclear antigen 1 (LANA1) prevents cis MHC class I peptide presentation.First Published Study with Embryonated Hen Egg Infected with Zika Virus Is Dated from 1952.Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mimics Epstein-Barr virus EBNA1 immune evasion through central repeat domain effects on protein processing.SIRT1 and AMPK pathways are essential for the proliferation and survival of primary effusion lymphoma cells.Impact of Epstein-Barr virus load, virus genotype, and frequency of the 30 bp deletion in the viral BNLF-1 gene in patients harboring the human immunodeficiency virus.Human bcl-2 expression, cleaved caspase-3, and KSHV LANA-1 in Kaposi sarcoma lesions.KSHV genotypes A and C are more frequent in Kaposi sarcoma lesions from Brazilian patients with and without HIV infection, respectively.Efficiencies and kinetics of infection in different cell types/lines by African and Asian strains of Zika virus
P50
Q24244835-DCF883A6-F81C-40C6-8E32-6E3AAE0FFC20Q24276745-0AD8BCED-2757-468C-AC53-FE5DE6C0370BQ34170639-E1286391-F27B-4953-AD9D-E33392119F16Q34383861-7D2B3B75-D26E-49E8-AAE7-0CDFAD8E4DFEQ36019773-2A9B4FB9-AD35-490A-A56E-9F70FAE5C534Q37692599-E1F26B56-7722-4894-B21B-82993916A0D0Q39001598-0F9647A2-6935-4524-B61B-4D480F2EF6E7Q39003177-E2413846-5D8D-40FE-B1B1-20BE6F3B2E1CQ39591598-FE19E39C-9F4D-496D-9A14-6EDEAD93121AQ40048153-131BF69F-4B85-498A-983E-82FC6444A8C4Q40128647-9E0A6EBA-B07F-4BA0-86C7-8343E861B270Q40250970-F47423CB-8D6B-4181-A03E-789DF2C1A8F5Q42271409-4D78AF5F-D75A-4E88-AC3C-9F3563B8D41EQ43653864-DEC99D20-5266-4F15-B64D-BAF40C31F39BQ45197756-1DA774E5-69C5-4859-A23C-B1D0970B9FA9Q59353127-27D31A0B-58BD-4F5A-814B-04B750EEEF73
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Suzane Ramos da Silva
@ast
Suzane Ramos da Silva
@en
Suzane Ramos da Silva
@es
Suzane Ramos da Silva
@nl
Suzane Ramos da Silva
@sl
type
label
Suzane Ramos da Silva
@ast
Suzane Ramos da Silva
@en
Suzane Ramos da Silva
@es
Suzane Ramos da Silva
@nl
Suzane Ramos da Silva
@sl
prefLabel
Suzane Ramos da Silva
@ast
Suzane Ramos da Silva
@en
Suzane Ramos da Silva
@es
Suzane Ramos da Silva
@nl
Suzane Ramos da Silva
@sl
P106
P1153
13404629900
P21
P31
P496
0000-0002-0768-8421